Skip to main content

Cervical Dysplasia

2
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
2
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Inovio Pharmaceuticals
2 programs
2
VGX-3100Phase 31 trial
VGX-3100Phase 31 trial
Active Trials
NCT03185013Completed201Est. Apr 2021
NCT03721978Completed203Est. Sep 2022
Integra LifeSciences
Integra LifeSciencesAustralia - Clayton
1 program
cervical conizationN/A1 trial
Active Trials
NCT00374114Completed20Est. Dec 2006

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Inovio PharmaceuticalsVGX-3100
Inovio PharmaceuticalsVGX-3100
Integra LifeSciencescervical conization

Clinical Trials (3)

Total enrollment: 424 patients across 3 trials

REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Start: Feb 2019Est. completion: Sep 2022203 patients
Phase 3Completed

REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Start: Jun 2017Est. completion: Apr 2021201 patients
Phase 3Completed

A Pilot Study to Evaluate Ultrasonic Surgical Aspiration as a Treatment Modality for Cervical Dysplasia

Start: Jan 2004Est. completion: Dec 200620 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 late-stage (Phase 3) programs, potential near-term approvals
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.